Hengrui’s Lucrative Dealmaking Year Continues With Braveheart

 
• By Joseph Haas
  
Hengrui makes its third big licensing deal with a western biopharma this year (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business